PRIMARY CARE SEQUENTIAL USE OF FIB-4 AND THE ENHANCED LIVER FIBROSIS TEST TO STRATIFY PATIENTS WITH NONALCOHOLIC FATTY LIVER ACIDE DOUBLES CIRRHOSIS DETECTION AND REDUCES REFERRALS OF PATIENTS WITH MILD DISEASE

被引：0
|
作者：
Srivastava, A. [1 ,2 ]
Gailer, R. [3 ]
Demma, S. [1 ,2 ]
Warner, A. [3 ]
Suri, D. [4 ]
Morgan, S.
Tanwar, S. [1 ]
Sennett, K. [5 ]
Thorburn, D. [1 ,2 ]
Parkes, J. [1 ,6 ]
Tsochatzis, E. [1 ,2 ]
Rosenberg, W. [1 ,2 ]
机构：
[1] UCL, Inst Liver & Digest Hlth, London, England
[2] Royal Free London NHS Fdn Trust, Hepatol & Liver Transplantat, London, England
[3] UCL, Primary Care & Populat Hlth, London, England
[4] Whittington Hosp, Dept Hepatol, London, England
[5] Islington Clin Commissioning Grp, Primary Care, London, England
[6] Univ Southampton, Publ Hlth Sci & Med Stat, Southampton, Hants, England
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)00802-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-280
引用
收藏
页码：S474 / S475
页数：2
相关论文
共 50 条
  • [1] Primary care sequential use of FIB-4 and the enhanced liver fibrosis test to stratify patients with non-alcoholic fatty liver disease increases cirrhosis detection and reduces referrals of patients with mild disease-2 year study analysis
    Srivastava, A.
    Gailer, R.
    Demma, S.
    Warner, A.
    Suri, D.
    Morgan, S.
    Sennett, K.
    Thorburn, D.
    Parkes, J.
    Tsochatzis, E.
    Rosenberg, W.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S68 - S68
  • [2] The combination of the enhanced liver fibrosis and FIB-4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease
    Younossi, Zobair M.
    Stepanova, Maria
    Felix, Sean
    Jeffers, Thomas
    Younossi, Elena
    Goodman, Zachary
    Racila, Andrei
    Lam, Brian P.
    Henry, Linda
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (12) : 1417 - 1422
  • [3] Correlation of Fibroscan with FIB-4 index for Assessment of Liver Fibrosis in patients with Nonalcoholic Fatty Liver Disease
    Tripathi, Brijendra Krishna
    Soni, Abhilasha
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 287 - 287
  • [4] The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan
    Seko, Yuya
    Yano, Kota
    Takahashi, Aya
    Okishio, Shinya
    Kataoka, Seita
    Okuda, Keiichiroh
    Umemura, Atsushi
    Yamaguchi, Kanji
    Moriguchi, Michihisa
    Tanaka, Saiyu
    Itoh, Yoshito
    DIAGNOSTICS, 2020, 10 (10)
  • [5] FIB-4 Predicts MACE and Cardiovascular Mortality in Patients With Nonalcoholic Fatty Liver Disease
    Chew, Nicholas W. S.
    Ng, Cheng Han
    Chan, Kai En
    Chee, Douglas
    Syn, Nicholas
    Tamaki, Nobuharu
    Muthiah, Mark
    Noureddin, Mazen
    CANADIAN JOURNAL OF CARDIOLOGY, 2022, 38 (11) : 1779 - 1780
  • [6] Impact of Age on Diagnostic Performance of FIB-4 for Detection of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease
    Siddiqui, Mohammad Shadab
    Yamada, Goro
    Vuppalanchi, Raj
    Van Natta, Mark
    Guy, Cynthia D.
    Kleiner, David
    Behling, Cynthia A.
    Brandman, Danielle
    Tonascia, James
    Chalasani, Naga P.
    Neuschwander-Tetri, Brent A.
    Sanyal, Arun J.
    HEPATOLOGY, 2018, 68 : 993A - 993A
  • [7] Fibroscan Compared to FIB-4, APRI, and AST/ALT Ratio for Assessment of Liver Fibrosis in Saudi Patients With Nonalcoholic Fatty Liver Disease
    Fallatah, Hind I.
    Akbar, Hisham O.
    Fallatah, Alyaa M.
    HEPATITIS MONTHLY, 2016, 16 (07)
  • [8] Ability of Cytokeratin-18 Fragments and FIB-4 Index to Diagnose Overall and Mild Fibrosis Nonalcoholic Steatohepatitis in Japanese Nonalcoholic Fatty Liver Disease Patients
    Kobayashi, Natsuko
    Kumada, Takashi
    Toyoda, Hidenori
    Tada, Toshifumi
    Ito, Takanori
    Kage, Masayoshi
    Okanoue, Takeshi
    Kudo, Masatoshi
    DIGESTIVE DISEASES, 2017, 35 (06) : 521 - 530
  • [9] Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease
    Younossi, Zobair M.
    Felix, Sean
    Jeffers, Thomas
    Younossi, Elena
    Nader, Fatema
    Pham, Huong
    Afendy, Arian
    Cable, Rebecca
    Racila, Andrei
    Younoszai, Zahra
    Lam, Brian P.
    Golabi, Pegah
    Henry, Linda
    Stepanova, Maria
    JAMA NETWORK OPEN, 2021, 4 (09)
  • [10] Using the Enhanced Liver Fibrosis test in Primary Care: A practical pathway to prioritise patients with fibrosis in Fatty Liver Disease
    Hinkson, Alexander
    Wong, Jo Ann
    Canter, Timothy
    Ong, Elaine
    Rowe, Ian
    Glynn, Paul
    Jones, Rebecca L.
    Parker, Richard
    JOURNAL OF HEPATOLOGY, 2021, 75 : S394 - S395
12345